Webcasts & Presentations

Webcasts
DateTitle
18 July 2018
Download Documentation Conference Call: Strategic Alliance with Tasly Pharmaceutical Group
31 May 2018
Download Documentation Financial Results for the Quarter Ended March 31, 2018
28 February 2018
Download Documentation Financial Results for the First Half Year Ended December 31, 2017
23 February 2018
Download Documentation Corporate Update: Phase 3 Trial Results in Acute Graft Versus Host Disease
15 November 2017
Download Documentation Financial Results for the Period Ended September 30, 2017
30 August 2017
Download Documentation Financial Results for the Three Months and for the Year Ended June 30, 2017
24 May 2017
Download Documentation Financial Results for the Period Ended March 31, 2017
26 February 2017
Download Documentation Financial Results for the Second Quarter/Half Year Ended December 31, 2016
16 February 2017
Download Documentation MPC-300-IV: Week 39 Results in Biological Refractory Rheumatoid Arthritis
15 November 2016
Download Documentation Mesoblast Reports Financial Results for Three Months Ended September 30, 2016
25 August 2016
Download Documentation Financial Results for Q4 and Year Ended 30 June 2016
09 August 2016
Download Documentation Phase 2 Trial Results In Biologic Refractory Rheumatoid Arthritis
Presentations
DateTitle 
31 May 2018
Download Documentation Financial Results for the Quarter Ended March 31, 2018
 
28 February 2018
Download Documentation Financial Results for First Half Year Ended December 31, 2017
 
23 February 2018
Download Documentation Phase 3 Day 28 Results in Steroid-Refractory Acute GVHD
 
11 January 2018
Download Documentation Presentation to J.P. Morgan 36th Annual Healthcare Conference
 
15 November 2017
Download Documentation Financial Results for the Period Ended September 30, 2017
 
23 October 2017
Download Documentation Notice of Annual General Meeting
 
30 August 2017
Download Documentation Financial Results for the Three Months and for the Year Ended June 30, 2017
 
25 May 2017
Download Documentation Third Quarter Results Presentation
 
27 February 2017
Download Documentation Half Year Results
 
16 February 2017
Download Documentation MPC-300-IV: Week 39 Results in Biological Refractory Rheumatoid Arthritis
 
13 January 2017
Download Documentation CEO Presentation to 35th Annual J.P. Morgan Healthcare Conference
 
22 November 2016
Download Documentation CEO Presentation to 2016 Annual General Meeting
 
15 November 2016
Download Documentation First Quarter Results Presentation
 
28 October 2016
Download Documentation Notice of Annual General Meeting
 
25 August 2016
Download Documentation 2016 Full Year Results
 
Get help downloading or viewing the above file types

Share Price ASX: MSB  AUD 1.55 as of Aug 17, 2018